BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7814065)

  • 1. A sequential study of humoral factors in ovarian neoplasms.
    Gupta SC; Agarwal J; Singh PA; Mehdiratta NK; Keswani NK
    Indian J Pathol Microbiol; 1994 Jul; 37(3):319-26. PubMed ID: 7814065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study of humoral factors in carcinoma cervix.
    Agarwal J; Gupta SC; Singh PA; Bisht D; Keswani NK
    Indian J Pathol Microbiol; 1992 Jan; 35(1):5-10. PubMed ID: 1452247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of circulating immune complexes and serum immunoglobulins in oral cancer patients--a follow up study.
    Parveen S; Taneja N; Bathi RJ; Deka AC
    Indian J Dent Res; 2010; 21(1):10-5. PubMed ID: 20427899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of ageing on the immune response to Schistosoma haematobium and hookworm by measuring circulating immune complexes, C3, IgG, IgA and IgM levels in residents of Omi dam area of Kogi State, Nigeria.
    Oyeyinka GO; Awogun IA; Akande TM; Awarun JA; Arinola OG; Salimonu LS
    Afr J Med Med Sci; 2003 Sep; 32(3):263-7. PubMed ID: 15030085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute phase reactants and circulating immune complexes in patients with ovarian carcinoma.
    Dobryszycka W; Gerber J; Zuwała-Jagiełło J; Ujec M
    Arch Immunol Ther Exp (Warsz); 1991; 39(1-2):41-50. PubMed ID: 1725104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-operative levels of serum immunoglobulins, circulating immune complexes and complement proteins in patients with different types of neoplasms.
    Gendek-Kubiak H; Grzegorczyk J; Gendek EG; Kowalski ML; Berner J
    Arch Immunol Ther Exp (Warsz); 2001; 49 Suppl 2():S89-95. PubMed ID: 11665753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A sequential study of circulating immune complexes, complement and immunoglobulins in borderline tuberculoid leprosy patients with and without reactions.
    Ramanathan VD; Thyagi P; Ramanathan U; Katoch K; Ramu G
    Indian J Lepr; 1998; 70(2):153-60. PubMed ID: 9724850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune reactive proteins in patients irradiated for cervical cancer. One year follow up.
    Juranić Z; Vucković-Dekić L; Durbaba M
    Neoplasma; 1994; 41(4):225-8. PubMed ID: 7935997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral immune responses to cathepsin D and glucose-regulated protein 78 in ovarian cancer patients.
    Chinni SR; Falchetto R; Gercel-Taylor C; Shabanowitz J; Hunt DF; Taylor DD
    Clin Cancer Res; 1997 Sep; 3(9):1557-64. PubMed ID: 9815843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sequential determination of circulating immune complexes in ovarian tumors].
    Beaufort F; Auner H; Lahousen M
    Wien Med Wochenschr; 1986 Jul; 136(13):317-22. PubMed ID: 3765649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble immune complexes and immunoglobulin (IgG, IgA and IgM) levels in Nigerians with primary liver cell carcinoma.
    Olubuyide IO; Salimonu LS; Adeniran SO
    Afr J Med Med Sci; 1993 Dec; 22(4):57-62. PubMed ID: 7839931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ovarian neoplasms. Immunoglobulin levels in patients with primary ovarian tumors].
    Wolff JP; de Oliveira CF
    J Gynecol Obstet Biol Reprod (Paris); 1975; 4(1):75-92. PubMed ID: 1230478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effects of occupational exposure to nitrogen dioxide (NO2) on the immunological parameters in workers].
    Rutowski J; Moszczyński P; Dobrowolski JW; Bem S; Krochmal D
    Med Pr; 1998; 49(4):341-51. PubMed ID: 9816580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-specific leucocyte migration inhibition of gynaecological carcinoma patients.
    Tosner J; Fixa B
    Clin Exp Immunol; 1979 Nov; 38(2):356-60. PubMed ID: 527267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoglobulin levels and lymphocyte subsets following cardiac operations: further evidence for a T-helper cell shifting.
    Lante W; Franke A; Weinhold C; Markewitz A
    Thorac Cardiovasc Surg; 2005 Feb; 53(1):16-22. PubMed ID: 15692913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoglobulin classes, complement factors and circulating immune complexes in chronic sinusitis patients.
    Ogunleye AO; Arinola OG
    Afr J Med Med Sci; 2001 Dec; 30(4):309-12. PubMed ID: 14510109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E-rosette forming lymphocytes and serum immunoglobulins in breast cancer patients.
    Singh RP; Singh VP; Udupa KN
    Mater Med Pol; 1991; 23(3):179-81. PubMed ID: 1842710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating IL-8 and anti-IL-8 autoantibody in patients with ovarian cancer.
    Lokshin AE; Winans M; Landsittel D; Marrangoni AM; Velikokhatnaya L; Modugno F; Nolen BM; Gorelik E
    Gynecol Oncol; 2006 Aug; 102(2):244-51. PubMed ID: 16434085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune reactive proteins in renal cell carcinoma patients treated by IFN alpha alone or in combination with vinblastine.
    Juranić Z; Stanojević-Bakić N; Maletić V; Borkovacki R
    Neoplasma; 1994; 41(4):229-32. PubMed ID: 7935998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of malignant ovarian neoplasms: a review of the literature. III. Immunological detection and ovarian cancer-associated antigens.
    Smith LH; Oi RH
    Obstet Gynecol Surv; 1984 Jun; 39(6):346-60. PubMed ID: 6203071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.